GNI Group Ltd. (TYO:2160)
2,266.00
-19.00 (-0.83%)
Apr 28, 2025, 2:45 PM JST
GNI Group Revenue
In the year 2024, GNI Group had annual revenue of 23.61B JPY, down -9.22%. GNI Group had revenue of 6.42B in the quarter ending December 31, 2024, with 17.50% growth.
Revenue
23.61B
Revenue Growth
-9.22%
P/S Ratio
4.86
Revenue / Employee
27.23M
Employees
867
Market Cap
114.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 23.61B | -2.40B | -9.22% |
Dec 31, 2023 | 26.01B | 8.59B | 49.33% |
Dec 31, 2022 | 17.42B | 4.73B | 37.26% |
Dec 31, 2021 | 12.69B | 2.92B | 29.85% |
Dec 31, 2020 | 9.77B | 2.33B | 31.25% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,579.02B |
HOYA Corporation | 838.60B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,912.32B |
Olympus | 993.33B |